BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Dagan Lonsdale//NONSGML Clinical pharmacology year 2 Pharmacokinetics 2 (PHA503) calendar//EN
CALSCALE:GREGORIAN
BEGIN:VEVENT
UID:9d5defeb-2dc3-427b-9495-a3d586356b0b
DTSTAMP:20251206T220049Z
DTSTART:20251002T140000Z
DTEND:20251002T150000Z
SUMMARY:PK 3.1 Introduction to the pharmacokinetics module in year 2 and pharmacokinetic Parameter Estimations preparation session
DESCRIPTION:Module - PHA503, Person delivering - Dagan and team
LOCATION:TBC
END:VEVENT
BEGIN:VEVENT
UID:b79e31ae-9966-48f7-9392-4af92c71bb0d
DTSTAMP:20251206T220049Z
DTSTART:20251007T090000Z
DTEND:20251007T100000Z
SUMMARY:PK 3.2 Parameter Estimations 1. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:6ae833bb-2a72-4631-9e04-bcb07f50c33c
DTSTAMP:20251206T220049Z
DTSTART:20251007T100000Z
DTEND:20251007T110000Z
SUMMARY:PK 3.2 Parameter Estimations 1. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:6b48b987-b38c-49f1-bda0-3ede920ae097
DTSTAMP:20251206T220049Z
DTSTART:20251007T110000Z
DTEND:20251007T120000Z
SUMMARY:PK 3.2 Parameter Estimations 1. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:39100e34-99e1-4aa2-8a38-5e49339a939a
DTSTAMP:20251206T220049Z
DTSTART:20251016T090000Z
DTEND:20251016T100000Z
SUMMARY:PK 3.4  Blood Brain Barrier
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:Self paced
END:VEVENT
BEGIN:VEVENT
UID:6cbb0592-c7da-40e5-84b4-0ba9c3fbacae
DTSTAMP:20251206T220049Z
DTSTART:20251017T140000Z
DTEND:20251017T150000Z
SUMMARY:PK 3.3 Pre-clinical PK and animal to human predictions
DESCRIPTION:Module - PHA503, Person delivering - Michael
LOCATION:Lecture theatre B
END:VEVENT
BEGIN:VEVENT
UID:30831fe3-83bc-4953-b41e-450ec7386e0c
DTSTAMP:20251206T220049Z
DTSTART:20251027T100000Z
DTEND:20251027T110000Z
SUMMARY:PK 3.5 Parameter Estimations 2. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Cleodie
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:ca18fcad-8a59-4ee8-b7d0-a9c7b5603177
DTSTAMP:20251206T220049Z
DTSTART:20251027T110000Z
DTEND:20251027T120000Z
SUMMARY:PK 3.5 Parameter Estimations 2. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Cleodie
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:93dfb2ca-b378-452c-ab79-e36dc8957657
DTSTAMP:20251206T220049Z
DTSTART:20251027T120000Z
DTEND:20251027T130000Z
SUMMARY:PK 3.5 Parameter Estimations 2. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Cleodie
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:a6fe1550-8357-45cb-b40d-34ae9f42597e
DTSTAMP:20251206T220049Z
DTSTART:20251030T120000Z
DTEND:20251030T130000Z
SUMMARY:PK 3.6 Introduction to topics for Thursday PM  Joint Drug devt and PK
DESCRIPTION:Module - PHA503, Person delivering - Michael
LOCATION:Self paced online
END:VEVENT
BEGIN:VEVENT
UID:c8ec0e29-d7c4-401d-bcad-1a97b41c67c5
DTSTAMP:20251206T220049Z
DTSTART:20251030T140000Z
DTEND:20251030T150000Z
SUMMARY:PK 3.7 study designs and choosing a dose at different clinical trial phases Joint PKDD session
DESCRIPTION:Module - PHA503, Person delivering - Ateeq/Toqa, external lecturer David Carlisle
LOCATION:Live online
END:VEVENT
BEGIN:VEVENT
UID:7e6a6cbc-b8bc-49a9-83ed-586573736776
DTSTAMP:20251206T220049Z
DTSTART:20251030T150000Z
DTEND:20251030T160000Z
SUMMARY:PK 3.7 study designs and choosing a dose at different clinical trial phases Joint PKDD session
DESCRIPTION:Module - PHA503, Person delivering - Ateeq/Toqa, external lecturer David Carlisle
LOCATION:Live online
END:VEVENT
BEGIN:VEVENT
UID:8185a767-df9f-4d48-9218-9503f5a7d2e7
DTSTAMP:20251206T220049Z
DTSTART:20251113T100000Z
DTEND:20251113T110000Z
SUMMARY:PK and drug development assignment drop in session
DESCRIPTION:Module - PHA503, Person delivering - Dagan, Ateeq
LOCATION:Live online
END:VEVENT
BEGIN:VEVENT
UID:ad22269d-75ba-4f3e-9307-3bb1f17e34bf
DTSTAMP:20251206T220049Z
DTSTART:20251113T110000Z
DTEND:20251113T120000Z
SUMMARY:PK 3.8 Pharmacogenomics
DESCRIPTION:Module - PHA503, Person delivering - Reya
LOCATION:Self paced online
END:VEVENT
BEGIN:VEVENT
UID:7a4cce7d-155c-4d29-831e-4c8f0939d594
DTSTAMP:20251206T220049Z
DTSTART:20251113T120000Z
DTEND:20251113T130000Z
SUMMARY:PK 3.9 Bioequivalence 2
DESCRIPTION:Module - PHA503, Person delivering - Toqa
LOCATION:TBC
END:VEVENT
BEGIN:VEVENT
UID:8f2c2efb-5a10-4fda-8b44-01459daafe40
DTSTAMP:20251206T220049Z
DTSTART:20251205T140000Z
DTEND:20251205T150000Z
SUMMARY:PK 3.10 Pharmacokinetics and PD in aging and pregnancy
DESCRIPTION:Module - PHA503, Person delivering - Cleodie
LOCATION:Lecture theatre B
END:VEVENT
BEGIN:VEVENT
UID:7b227342-927c-4500-877c-aabb892e4a4a
DTSTAMP:20251206T220049Z
DTSTART:20251205T150000Z
DTEND:20251205T160000Z
SUMMARY:PK 3.10 Pharmacokinetics and PD in aging and pregnancy
DESCRIPTION:Module - PHA503, Person delivering - Cleodie
LOCATION:Lecture theatre B
END:VEVENT
BEGIN:VEVENT
UID:60160308-79c1-4bf4-bfbe-55fe68fd441f
DTSTAMP:20251206T220049Z
DTSTART:20251208T100000Z
DTEND:20251208T110000Z
SUMMARY:PK 3.11 Pharmacokinetic Variability
DESCRIPTION:Module - PHA503, Person delivering - Michael
LOCATION:Lecture theatre A
END:VEVENT
BEGIN:VEVENT
UID:84301d23-638e-4081-8f3e-de5e2fb708d8
DTSTAMP:20251206T220049Z
DTSTART:20260108T140000Z
DTEND:20260108T150000Z
SUMMARY:PK 3.12  Introduction to PK modelling
DESCRIPTION:Module - PHA503, Person delivering - Prof. Joe Standing
LOCATION:Self-paced
END:VEVENT
BEGIN:VEVENT
UID:36b20780-7ecf-4f27-be7c-3fa8b12212bc
DTSTAMP:20251206T220049Z
DTSTART:20260108T150000Z
DTEND:20260108T160000Z
SUMMARY:PK 3.13  Introduction to Compartmental analysis
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:Live online
END:VEVENT
END:VCALENDAR
